UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors
  • Products

     

     

     

     

     

    Briviact®, Cimzia®, FINTEPLA®, Keppra XR®, Keppra®, Nayzilam®, Neupro® , RYSTIGGO®   and ZILBRYSQ® are registered trademarks of the UCB Group of Companies.  Vimpat® is a registered trademark used under license from Harris FRC Corporation.